A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast Cancer

Inclusion Criteria: * Advanced or metastatic breast cancer * Disease that can be measured by the physician or radiologic test. * May have had one chemotherapy treatment for advanced or metastatic disease. * Patients may have received any prior adjuvant chemotherapy, including taxane containing regimens, provided this treatment was completed at least 6 months prior to enrollment. * Patients may have received prior hormone therapy or immunotherapy. Exclusion Criteria: * Patients with only non-measurable disease * Cancer that has spread to the brain * A patient who received a taxane with metastatic disease. * Pregnancy * Patients who received prior gemcitabine